Ignite Planners, LLC Edwards Lifesciences Corp Transaction History

Ignite Planners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$69.28 - $93.38 $138 - $186	2 Added 0.03%	6,397 $443,000
Q2 2023 Jul 11, 2023	SELL	$81.41 - $94.33 $54,951 - $63,672	-675 Reduced 9.55%	6,395 $603,000
Q4 2022 Feb 02, 2023	BUY	$68.3 - $87.44 $119,320 - $152,757	1,747 Added 32.82%	7,070 $527,000
Q3 2022 Oct 12, 2022	SELL	$82.37 - $107.29 $78,416 - $102,140	-952 Reduced 15.17%	5,323 $455,000
Q2 2022 Jul 15, 2022	SELL	$86.5 - $128.27 $778,846 - $1.15 Million	-9,004 Reduced 58.93%	6,275 $617,000
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $43,231 - $54,416	424 Added 2.85%	15,279 $1.81 Million
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $1.58 Million - $1.94 Million	14,855 New	14,855 $1.72 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ignite Planners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ignite Planners, LLC with notifications on news.